CL2009000275A1 - Compuestos derivados de furo [3,2-c]piridina y tieno [3,2-c] piridina; composicion farmaceutica que los comprende; y su uso en el tratamiento del cancer. - Google Patents
Compuestos derivados de furo [3,2-c]piridina y tieno [3,2-c] piridina; composicion farmaceutica que los comprende; y su uso en el tratamiento del cancer.Info
- Publication number
- CL2009000275A1 CL2009000275A1 CL2009000275A CL2009000275A CL2009000275A1 CL 2009000275 A1 CL2009000275 A1 CL 2009000275A1 CL 2009000275 A CL2009000275 A CL 2009000275A CL 2009000275 A CL2009000275 A CL 2009000275A CL 2009000275 A1 CL2009000275 A1 CL 2009000275A1
- Authority
- CL
- Chile
- Prior art keywords
- pyridine
- furo
- thieno
- cancer
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compuestos derivados de furo [3,2.c]piridina y tieno [3,2-c] piridina y sus sales farmacéuticamente aceptables; composición farmacéutica; y su uso en el tratamiento del cáncer, sarcoma, melanoma, retinoblastoma, neuroblastoma, entre otras, que comprende una desregulación de la transmisión mesenquimal epitelial.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6380008P | 2008-02-06 | 2008-02-06 | |
US11955308P | 2008-12-03 | 2008-12-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2009000275A1 true CL2009000275A1 (es) | 2009-06-12 |
Family
ID=40524808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2009000275A CL2009000275A1 (es) | 2008-02-06 | 2009-02-06 | Compuestos derivados de furo [3,2-c]piridina y tieno [3,2-c] piridina; composicion farmaceutica que los comprende; y su uso en el tratamiento del cancer. |
Country Status (19)
Country | Link |
---|---|
US (1) | US8022206B2 (es) |
EP (1) | EP2265616B8 (es) |
JP (1) | JP2011511094A (es) |
KR (1) | KR20110014971A (es) |
CN (1) | CN102007127A (es) |
AR (1) | AR070317A1 (es) |
AU (1) | AU2009212338A1 (es) |
BR (1) | BRPI0908050A2 (es) |
CA (1) | CA2711078A1 (es) |
CL (1) | CL2009000275A1 (es) |
EA (1) | EA201070929A1 (es) |
ES (1) | ES2451024T3 (es) |
IL (1) | IL206758A0 (es) |
MX (1) | MX2010008638A (es) |
PE (1) | PE20091414A1 (es) |
TW (1) | TW200944201A (es) |
UY (1) | UY31638A1 (es) |
WO (1) | WO2009100282A1 (es) |
ZA (1) | ZA201005554B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2534156A1 (en) * | 2010-02-11 | 2012-12-19 | OSI Pharmaceuticals, LLC | 7-aminofuropyridine derivatives |
WO2011109593A1 (en) | 2010-03-03 | 2011-09-09 | OSI Pharmaceuticals, LLC | Substituted-5-aminopyrrolo/pyrazolopyridines |
JP2013525476A (ja) * | 2010-05-04 | 2013-06-20 | ファイザー・インク | Alk阻害剤としての複素環式誘導体 |
WO2012003338A1 (en) | 2010-07-01 | 2012-01-05 | Takeda Pharmaceutical Company Limited | COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
TWI504350B (zh) * | 2010-09-01 | 2015-10-21 | Du Pont | 殺真菌吡唑及其混合物 |
US10614666B2 (en) | 2011-04-20 | 2020-04-07 | Video Gaming Technologies, Inc. | Gaming machines with free play bonus mode presenting only winning outcomes |
EP3815685A3 (en) | 2011-10-31 | 2021-10-13 | The Methodist Hospital Research Institute | Compound comprising a mao targeting/seeker moiety for treating human gliomas |
EP2828267B1 (en) | 2012-03-23 | 2019-10-30 | Memorial Sloan-Kettering Cancer Center | TREATMENT OF PANCREATIC AND RELATED CANCERS WITH 5-ACYL-6,7-DIHYDROTHIENO[3,2-c]PYRIDINES |
WO2013152252A1 (en) | 2012-04-06 | 2013-10-10 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
KR101582852B1 (ko) | 2012-05-24 | 2016-01-07 | 서울대학교 산학협력단 | 타우 단백질 매개 신경 퇴행성 질환 치료제 |
AU2014302365B2 (en) | 2013-06-26 | 2018-11-15 | Abbvie Inc. | Primary carboxamides as BTK inhibitors |
US9907791B2 (en) * | 2014-03-14 | 2018-03-06 | University Of Utah Research Foundation | Ron inhibitors for use in preventing and treating bone loss |
CN103923081B (zh) * | 2014-04-14 | 2017-06-27 | 武汉光谷人福生物医药有限公司 | 化合物及其制备方法和应用 |
ES2764299T3 (es) | 2014-12-09 | 2020-06-02 | Inst Nat Sante Rech Med | Anticuerpos monoclonales humanos contra AXL |
WO2016135041A1 (en) | 2015-02-26 | 2016-09-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Fusion proteins and antibodies comprising thereof for promoting apoptosis |
CN106866447A (zh) * | 2017-03-30 | 2017-06-20 | 成都绿林科技有限公司 | 一种合成对乙酰基苯甲酰胺的方法 |
US10957159B2 (en) | 2018-04-12 | 2021-03-23 | Aristocrat Technologies Australia Pty Limited | Gaming machine and method for displaying a free spin count-up |
US11427596B2 (en) * | 2019-07-19 | 2022-08-30 | Indian Institute of Technology Indore | Metal-free solvent-free synthesis of fused-pyrido heterocycles and biomedical applications |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP2003002929A0 (en) | 2001-06-23 | 2003-12-31 | Aventis Pharma Inc | Pyrrolopyrimidines as protein kinase inhibitors |
US20040235867A1 (en) * | 2001-07-24 | 2004-11-25 | Bilodeau Mark T. | Tyrosine kinase inhibitors |
US20040014755A1 (en) | 2002-01-10 | 2004-01-22 | Dhanapalan Nagarathnam | Rho-kinase inhibitors |
US7704995B2 (en) | 2002-05-03 | 2010-04-27 | Exelixis, Inc. | Protein kinase modulators and methods of use |
CL2003002287A1 (es) * | 2002-11-25 | 2005-01-14 | Wyeth Corp | COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS |
US7276519B2 (en) * | 2002-11-25 | 2007-10-02 | Wyeth | Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
JP2006516626A (ja) | 2003-01-28 | 2006-07-06 | スミスクライン ビーチャム コーポレーション | 化学的化合物 |
DK2476667T3 (da) | 2003-02-26 | 2014-09-15 | Sugen Inc | Aminoheteroaryl-forbindelser som proteinkinase-inhibitorer |
EP1620094A4 (en) * | 2003-05-06 | 2010-04-28 | Glaxosmithkline Llc | NEW CHEMICAL COMPOUNDS |
US20050026944A1 (en) * | 2003-07-24 | 2005-02-03 | Patrick Betschmann | Thienopyridine and furopyridine kinase inhibitors |
US7674907B2 (en) * | 2004-07-23 | 2010-03-09 | Amgen Inc. | Furanopyridine derivatives and methods of use |
US7361764B2 (en) | 2004-07-27 | 2008-04-22 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
US7709645B2 (en) | 2004-07-27 | 2010-05-04 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
GEP20104906B (en) | 2004-08-26 | 2010-02-25 | Pfizer | Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
RS51601B (en) | 2004-08-26 | 2011-08-31 | Pfizer Inc. | PYRAZOLS SUBSTITUTED BY AMINOHETEROARYL UNITS AS PROTEIN KINASE INHIBITORS |
CA2578075A1 (en) | 2004-08-26 | 2006-03-02 | Pfizer Inc. | Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
MX2007012448A (es) * | 2005-04-06 | 2007-10-19 | Astrazeneca Ab | Heterociclos sustituidos y su uso como inhibidores de chk1, pdk1 y pak. |
MX2008002060A (es) * | 2005-08-16 | 2008-04-16 | Hoffmann La Roche | Nuevas amidas de acido 4-amino-tieno[3,2-c]piridin-7-carboxilico. |
KR20080052630A (ko) * | 2005-09-01 | 2008-06-11 | 어레이 바이오파마 인크. | Raf 억제제 화합물 및 그의 사용 방법 |
WO2007056625A2 (en) * | 2005-11-04 | 2007-05-18 | Smithkline Beecham Corporation | Thienopyridine b-raf kinase inhibitors |
NZ568289A (en) | 2005-12-05 | 2011-06-30 | Pfizer Prod Inc | Polymorphs of (R)-3-[1-(2,6-dichloro-3-fluoro-phenyl)-ethoxy]-5-(1- piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine |
US7989461B2 (en) * | 2005-12-23 | 2011-08-02 | Amgen Inc. | Substituted quinazolinamine compounds for the treatment of cancer |
EP2004625B1 (en) | 2006-03-22 | 2009-12-30 | Vertex Pharmaceuticals Incorporated | C-met protein kinase inhibitors for the treatment of proliferative disorders |
WO2007124181A2 (en) * | 2006-04-21 | 2007-11-01 | Amgen Inc. | Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use |
US7601716B2 (en) | 2006-05-01 | 2009-10-13 | Cephalon, Inc. | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors |
GB0625659D0 (en) | 2006-12-21 | 2007-01-31 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
AU2007336811A1 (en) | 2006-12-21 | 2008-07-03 | Plexxikon, Inc. | Compounds and methods for kinase modulation, and indications therefor |
PE20121126A1 (es) | 2006-12-21 | 2012-08-24 | Plexxikon Inc | Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa |
TW200908968A (en) | 2007-05-29 | 2009-03-01 | Sgx Pharmaceuticals Inc | Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators |
WO2009053737A2 (en) | 2007-10-25 | 2009-04-30 | Astrazeneca Ab | Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders |
AR069393A1 (es) | 2007-11-21 | 2010-01-20 | Imclone Systems Inc | Inhibicion del receptor para la proteina estimulante del macrofago (ron) y metodos para el tratamiento del mismo |
EP2288383A1 (en) | 2008-05-14 | 2011-03-02 | Amgen, Inc | Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer |
KR101034351B1 (ko) | 2008-05-14 | 2011-05-16 | 한국화학연구원 | 신규 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의약학적으로 허용가능한 염, 이의 제조방법 및 이를유효성분으로 함유하는 이상세포 성장 질환의 예방 및치료용 약학적 조성물 |
-
2009
- 2009-01-29 AR ARP090100283A patent/AR070317A1/es unknown
- 2009-02-04 TW TW098103558A patent/TW200944201A/zh unknown
- 2009-02-05 PE PE2009000178A patent/PE20091414A1/es not_active Application Discontinuation
- 2009-02-05 UY UY031638A patent/UY31638A1/es not_active Application Discontinuation
- 2009-02-06 CL CL2009000275A patent/CL2009000275A1/es unknown
- 2009-02-06 US US12/366,743 patent/US8022206B2/en not_active Expired - Fee Related
- 2009-02-06 EA EA201070929A patent/EA201070929A1/ru unknown
- 2009-02-06 AU AU2009212338A patent/AU2009212338A1/en not_active Abandoned
- 2009-02-06 ES ES09709265.4T patent/ES2451024T3/es active Active
- 2009-02-06 KR KR1020107019308A patent/KR20110014971A/ko not_active Application Discontinuation
- 2009-02-06 WO PCT/US2009/033311 patent/WO2009100282A1/en active Application Filing
- 2009-02-06 BR BRPI0908050-3A patent/BRPI0908050A2/pt not_active IP Right Cessation
- 2009-02-06 JP JP2010546027A patent/JP2011511094A/ja not_active Ceased
- 2009-02-06 CA CA2711078A patent/CA2711078A1/en not_active Abandoned
- 2009-02-06 CN CN2009801092027A patent/CN102007127A/zh active Pending
- 2009-02-06 MX MX2010008638A patent/MX2010008638A/es active IP Right Grant
- 2009-02-06 EP EP09709265.4A patent/EP2265616B8/en active Active
-
2010
- 2010-07-01 IL IL206758A patent/IL206758A0/en unknown
- 2010-08-04 ZA ZA2010/05554A patent/ZA201005554B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN102007127A (zh) | 2011-04-06 |
WO2009100282A1 (en) | 2009-08-13 |
AU2009212338A1 (en) | 2009-08-13 |
CA2711078A1 (en) | 2009-08-13 |
ES2451024T3 (es) | 2014-03-26 |
US8022206B2 (en) | 2011-09-20 |
ZA201005554B (en) | 2011-04-28 |
EA201070929A1 (ru) | 2011-04-29 |
US20090197864A1 (en) | 2009-08-06 |
JP2011511094A (ja) | 2011-04-07 |
BRPI0908050A2 (pt) | 2015-08-11 |
KR20110014971A (ko) | 2011-02-14 |
IL206758A0 (en) | 2010-12-30 |
EP2265616B1 (en) | 2013-11-20 |
EP2265616A1 (en) | 2010-12-29 |
MX2010008638A (es) | 2010-08-30 |
AR070317A1 (es) | 2010-03-31 |
UY31638A1 (es) | 2009-09-30 |
PE20091414A1 (es) | 2009-09-23 |
TW200944201A (en) | 2009-11-01 |
EP2265616B8 (en) | 2014-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009000275A1 (es) | Compuestos derivados de furo [3,2-c]piridina y tieno [3,2-c] piridina; composicion farmaceutica que los comprende; y su uso en el tratamiento del cancer. | |
ECSP20003147A (es) | Carboxamidas como moduladores de los canales de sodio | |
UY31124A1 (es) | Derivados de oxiadazol y su uso como potenciadores del receptor metabotropico de glutamato - 842 | |
CL2012003421A1 (es) | Compuestos derivados de 3-amino-n-(4-carbamoilpiridin-3-il)(aril/heteroaril)-2-carboxamida; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad del snc, oncologica, entre otras. pct fase nacional | |
CY1120032T1 (el) | Πυραζολυλικες και πυριμιδιυλικες τρικυκλικες ενονες ως αντιοξειδωτικοι ρυθμιστες φλεγμονης | |
NI201000041A (es) | Derivados y composiciones que comprenden quinazolinona 6-, 7-, u 8 - sustituida y métodos para utilizar la misma. | |
CL2008002538A1 (es) | Compuestos derivados de indol sustituidos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral | |
CL2008002539A1 (es) | Compuestos derivados de indol sustituidos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral | |
NI201200132A (es) | Derivados de arilmetoxi isoindolina y composiciones que los comprenden y metodos para utilizar los mismos | |
UY34220A (es) | Indazoles, composiciones farmacéuticas y uso de los mismos | |
CR11819A (es) | Compuestos de isoindolina 5-sustituidos | |
UY31436A1 (es) | Nuevos compuestos tetracíclicos | |
NI200900040A (es) | Derivados de quinazolinona 5-substituidos como agentes antitumorales. | |
HN2006035237A (es) | Derivados de triazolopiridina en calidad de inhibidores de lipasas y fosfolipasas | |
NI201000005A (es) | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico. | |
UY30977A1 (es) | Derivados de isoindolinas 4' -o-sustituidas. composiciones que las contienen y metodos para sus usos. | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
CL2008003406A1 (es) | Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih. | |
AR062875A1 (es) | Compuestos de n- metilaminometil isoindol y composiciones que los comprenden y metodos para utilizarlos | |
UY31127A1 (es) | Ligandos de oxiadazol del receptor metabotropico para el glutamato y su utilizacion como potenciadores - 841 | |
CR20130309A (es) | Derivados de biciclo [3,2,1] octilamida y sus usos | |
CR20140216A (es) | 5,7-imidazo[1,2-c]pirimidinas sustituidas | |
CL2008001157A1 (es) | Compuestos derivados de quinolina-carboxamida, antagonistas de p2y12; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; composicion de una combinacion de dichos compuestos; y uso del compuesto en el tratamiento de trastornos cardiovasculares, tromboembolismo, infarto agudo al miocardio. | |
HN2008001393A (es) | Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
CR11098A (es) | Compuestos de pirido [2,3-d] pirimidina-7-ona como inhibidores de p13k-alfa para el tratamiento del cancer |